My 10 Favorite Stocks for 2024
Stocks you need to know
It’s the last day of the year.
2024 will be a year full of amazing opportunities.
Today you’ll find out about my 10 favorite stocks for 2024.
10 Favorite Stocks 2024
10. Ameriprise Financial ($AMP)
Ameriprise Financial is a company providing financial planning, investment management, and advisory services.
They work with individuals, businesses, and institutions to offer a range of financial products including retirement planning, wealth management, insurance, and asset management solutions.
Cannibal stock (outstanding shares decreased by almost 50% since 2014)
Cheap valuation: PE of 12.8x
Heavy share buybacks + cheap valuation = great for investors
9. Text SA ($TXT)
Text SA is a Software as a Service (SaaS) company. Almost all its revenue is recurring in nature.
The company manages text communication with customers both in business-to-consumer (B2C) and business-to-business (B2B) sectors.
Overlooked Compounding Machine
Net profit margin of over 50% (!)
Trading at very cheap valuation levels (PE: 16.1x)
8. Medpace ($MEDP)
Medpace is a Clinical Research Organization that executes (pre)clinical tests for biotechnology companies.
It’s important to highlight that Medpace itself is not a biotechnology company. They help biotechnology companies execute their clinical tests, providing them with robust cash flows.
Owner-Operator Quality Stock
The end market should be able to grow by 11.5% (!) per year until 2030
Medpace is a great example of a wonderful company at a fair price
7. LVMH ($MC)
LVMH is a global producer and distributor of luxury goods.
The French company is a dominant force in the luxury industry with a diverse portfolio of brands that cover a wide range of consumer products and experiences.
Bernard Arnault is an excellent Owner-Operator
Strong moat based on pricing power and an excellent reputation
Healthy fundamentals and a strongly growing end market
6. Kinsale Capital ($KNSL)
Kinsale Capital is an insurance company specializing in excess and surplus lines insurance.
They focus on providing coverage for hard-to-place risks or unique insurance needs that may not be served by standard insurance companies.
Founder and CEO Michael Kehoe is a strong asset for the company
The stock fell significantly after the publication of its Q3 results
Management targets 10-20% growth per year